T

Turning Point Therapeutics

150 employees

Turning Point Therapeutics is a pharmaceutical company that discovers and develops precision medicines for cancer and other diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Pharmaceutical

ROS1

G2032R

Oncology

FAK

JAK2

NSCLC

NTRK3

NTRK2

NTRK1

MASC

oncogenic

ALK

Drug resistance

SRC

Structure-based design

fusion gene

Health Care

Precision medicine

G1202R

NTRK

Therapeutics

metastasis

Date founded

2013

Funding rounds raised

Total raised

$80M

from 13 investors over 13 rounds

T

Turning Point Therapeutics raised $80M on October 19, 2018

Investors: Lilly Asia Ventures, Nextech Invest, Kenson Ventures, Foresite Capital, venBio Partners, S.R. One Ltd and OrbiMed Advisors

T

Turning Point Therapeutics raised $45M on May 23, 2017

Investors: Lilly Asia Ventures, OrbiMed Advisors, S.R. One Ltd and SV Tech Ventures

T

Turning Point Therapeutics raised $18M on March 21, 2016

Investors: CRCM Ventures

T

Turning Point Therapeutics raised undisclosed on July 28, 2015